Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9736 per EA under NDC 00378300177. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the candesartan cilexetil and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB
candesartan cilexetil and hydrochlorothiazideStrength
16; 12.5 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378300177
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090704On Market Since
12/4/2012
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9736 per EA |
|---|---|
| All-time high | $3.6028 (Mar 15, 2017) |
| All-time low | $0.6502 (Nov 20, 2024) |
| 52-week high | $1.1441 |
| 52-week low | $0.7758 |
| Median price | $2.0633 |
| Average price | $2.0370 |
| Largest weekly change | +59.6% (Jul 20, 2016) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, manufactured by Mylan Pharmaceuticals Inc., is $0.9736 per EA (NDC 00378300177), effective Jun 24, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has declined 37.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
Since Nov 28, 2013, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has ranged from a low of $0.6502 (Nov 20, 2024) to a high of $3.6028 (Mar 15, 2017), with a median of $2.0633 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB (NDC 00378300177) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification